Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-018775

Director sold 12,866 shares at $8.04 ($103,443)

  • Director acquired 16,745 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hutson Nancy J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-13 Grant or award : show line 1 in the form +16,745 94,684 D
2023-06-14 Sale : show line 2 in the form −12,866 $8.04 $103,443 81,818 D
Open-market sales · 12,866 sh · avg $8.04 · $103,443

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-13 Grant or award : show line 3 in the form Automatic Stock Option Grant +39,072 39,072 D
Loading xslF345X04/form4.xml…